CN102803491A - 用于在酵母细胞表面上展示多肽的方法和组合物 - Google Patents
用于在酵母细胞表面上展示多肽的方法和组合物 Download PDFInfo
- Publication number
- CN102803491A CN102803491A CN2011800148893A CN201180014889A CN102803491A CN 102803491 A CN102803491 A CN 102803491A CN 2011800148893 A CN2011800148893 A CN 2011800148893A CN 201180014889 A CN201180014889 A CN 201180014889A CN 102803491 A CN102803491 A CN 102803491A
- Authority
- CN
- China
- Prior art keywords
- polypeptide
- nucleotide sequence
- antibody polypeptides
- cell
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 93
- 239000000203 mixture Substances 0.000 title claims abstract description 31
- 210000005253 yeast cell Anatomy 0.000 title abstract description 94
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 554
- 229920001184 polypeptide Polymers 0.000 claims abstract description 547
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 547
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 337
- 239000012634 fragment Substances 0.000 claims abstract description 183
- 210000004027 cell Anatomy 0.000 claims description 251
- 125000003729 nucleotide group Chemical group 0.000 claims description 207
- 230000014509 gene expression Effects 0.000 claims description 205
- 239000002773 nucleotide Substances 0.000 claims description 205
- 230000004927 fusion Effects 0.000 claims description 109
- 101710112477 Phycobiliprotein ApcE Proteins 0.000 claims description 64
- 102100038895 Myc proto-oncogene protein Human genes 0.000 claims description 40
- 101710135898 Myc proto-oncogene protein Proteins 0.000 claims description 40
- 101710150448 Transcriptional regulator Myc Proteins 0.000 claims description 40
- 230000001939 inductive effect Effects 0.000 claims description 39
- 108020004705 Codon Proteins 0.000 claims description 38
- 238000012360 testing method Methods 0.000 claims description 38
- 230000006698 induction Effects 0.000 claims description 29
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 claims description 27
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 claims description 27
- 230000013011 mating Effects 0.000 claims description 22
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 21
- 238000011534 incubation Methods 0.000 claims description 19
- 150000007523 nucleic acids Chemical group 0.000 claims description 14
- 102100034613 Annexin A2 Human genes 0.000 claims description 12
- 101000924474 Homo sapiens Annexin A2 Proteins 0.000 claims description 12
- 102000006010 Protein Disulfide-Isomerase Human genes 0.000 claims description 12
- 108020003519 protein disulfide isomerase Proteins 0.000 claims description 12
- 230000003362 replicative effect Effects 0.000 claims description 11
- 108010006519 Molecular Chaperones Proteins 0.000 claims description 10
- 230000010354 integration Effects 0.000 claims description 10
- 210000002415 kinetochore Anatomy 0.000 claims description 9
- 230000010076 replication Effects 0.000 claims description 9
- 101100215634 Yarrowia lipolytica (strain CLIB 122 / E 150) XPR2 gene Proteins 0.000 claims description 8
- BCCRXDTUTZHDEU-VKHMYHEASA-N Gly-Ser Chemical compound NCC(=O)N[C@@H](CO)C(O)=O BCCRXDTUTZHDEU-VKHMYHEASA-N 0.000 claims description 6
- 239000000969 carrier Substances 0.000 claims description 6
- 108010033706 glycylserine Proteins 0.000 claims description 6
- 230000008676 import Effects 0.000 claims description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 4
- 108010023063 Bacto-peptone Proteins 0.000 claims description 4
- 229930003756 Vitamin B7 Natural products 0.000 claims description 4
- 229940041514 candida albicans extract Drugs 0.000 claims description 4
- 230000004048 modification Effects 0.000 claims description 4
- 238000012986 modification Methods 0.000 claims description 4
- 239000011735 vitamin B7 Substances 0.000 claims description 4
- 235000011912 vitamin B7 Nutrition 0.000 claims description 4
- 239000012138 yeast extract Substances 0.000 claims description 4
- 102100037620 Centrin-1 Human genes 0.000 claims description 3
- 102100037633 Centrin-3 Human genes 0.000 claims description 3
- 102000005720 Glutathione transferase Human genes 0.000 claims description 3
- 108010070675 Glutathione transferase Proteins 0.000 claims description 3
- 101710154606 Hemagglutinin Proteins 0.000 claims description 3
- 101000880499 Homo sapiens Centrin-1 Proteins 0.000 claims description 3
- 101000880522 Homo sapiens Centrin-3 Proteins 0.000 claims description 3
- 101100084403 Homo sapiens PRODH gene Proteins 0.000 claims description 3
- 101710093908 Outer capsid protein VP4 Proteins 0.000 claims description 3
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 claims description 3
- 101150059359 POX2 gene Proteins 0.000 claims description 3
- 102100028772 Proline dehydrogenase 1, mitochondrial Human genes 0.000 claims description 3
- 101710176177 Protein A56 Proteins 0.000 claims description 3
- 101100029251 Zea mays PER2 gene Proteins 0.000 claims description 3
- 230000001413 cellular effect Effects 0.000 claims description 3
- 239000000185 hemagglutinin Substances 0.000 claims description 3
- 235000014304 histidine Nutrition 0.000 claims description 3
- 150000002411 histidines Chemical class 0.000 claims description 2
- 238000005204 segregation Methods 0.000 claims description 2
- 241000235015 Yarrowia lipolytica Species 0.000 abstract description 13
- 241000235013 Yarrowia Species 0.000 abstract description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 268
- 229960000575 trastuzumab Drugs 0.000 description 69
- 239000000427 antigen Substances 0.000 description 42
- 108091007433 antigens Proteins 0.000 description 42
- 102000036639 antigens Human genes 0.000 description 42
- 239000002609 medium Substances 0.000 description 25
- 239000013612 plasmid Substances 0.000 description 24
- 108090000623 proteins and genes Proteins 0.000 description 23
- 230000001580 bacterial effect Effects 0.000 description 22
- 238000004113 cell culture Methods 0.000 description 22
- 102000004169 proteins and genes Human genes 0.000 description 22
- 235000018102 proteins Nutrition 0.000 description 21
- 230000012010 growth Effects 0.000 description 17
- 241000894007 species Species 0.000 description 17
- 150000001413 amino acids Chemical class 0.000 description 16
- 239000013613 expression plasmid Substances 0.000 description 14
- 101500008191 Turnip yellow mosaic virus Putative helicase Proteins 0.000 description 13
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 12
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 12
- 235000001014 amino acid Nutrition 0.000 description 12
- 238000005516 engineering process Methods 0.000 description 11
- 239000002953 phosphate buffered saline Substances 0.000 description 9
- 101100001141 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) AGA1 gene Proteins 0.000 description 8
- 210000002421 cell wall Anatomy 0.000 description 8
- 238000001514 detection method Methods 0.000 description 8
- 238000000684 flow cytometry Methods 0.000 description 8
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 8
- 230000006872 improvement Effects 0.000 description 8
- 239000003550 marker Substances 0.000 description 8
- 241000235036 Debaryomyces hansenii Species 0.000 description 7
- 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 7
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 7
- 230000000890 antigenic effect Effects 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 230000000295 complement effect Effects 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 231100000673 dose–response relationship Toxicity 0.000 description 7
- 230000035772 mutation Effects 0.000 description 7
- 230000003864 performance function Effects 0.000 description 7
- 238000012545 processing Methods 0.000 description 7
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 6
- 230000002349 favourable effect Effects 0.000 description 6
- 108700012830 rat Lip2 Proteins 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 230000028327 secretion Effects 0.000 description 6
- 230000000153 supplemental effect Effects 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 241000235058 Komagataella pastoris Species 0.000 description 5
- 241000223252 Rhodotorula Species 0.000 description 5
- 238000004873 anchoring Methods 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000004043 dyeing Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 108020001507 fusion proteins Proteins 0.000 description 5
- 102000037865 fusion proteins Human genes 0.000 description 5
- 239000000833 heterodimer Substances 0.000 description 5
- 238000010820 immunofluorescence microscopy Methods 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- 239000013642 negative control Substances 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 102000039446 nucleic acids Human genes 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 238000000954 titration curve Methods 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- 230000001131 transforming effect Effects 0.000 description 5
- 238000009423 ventilation Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 101710100968 Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 4
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 4
- 102100021651 SUN domain-containing ossification factor Human genes 0.000 description 4
- 108091023040 Transcription factor Proteins 0.000 description 4
- 102000040945 Transcription factor Human genes 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 239000002523 lectin Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000007320 rich medium Substances 0.000 description 4
- 102220097943 rs876659950 Human genes 0.000 description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 3
- IAHOUQOWMXVMEH-UHFFFAOYSA-N 2,4,6-trinitroaniline Chemical compound NC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O IAHOUQOWMXVMEH-UHFFFAOYSA-N 0.000 description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 241001527609 Cryptococcus Species 0.000 description 3
- 241000235646 Cyberlindnera jadinii Species 0.000 description 3
- 244000286779 Hansenula anomala Species 0.000 description 3
- 235000014683 Hansenula anomala Nutrition 0.000 description 3
- 244000285963 Kluyveromyces fragilis Species 0.000 description 3
- 235000014663 Kluyveromyces fragilis Nutrition 0.000 description 3
- 241001138401 Kluyveromyces lactis Species 0.000 description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 3
- 241001443590 Naganishia albida Species 0.000 description 3
- 239000005642 Oleic acid Substances 0.000 description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
- 241000235347 Schizosaccharomyces pombe Species 0.000 description 3
- 230000009824 affinity maturation Effects 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 3
- 238000010195 expression analysis Methods 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 229930004094 glycosylphosphatidylinositol Natural products 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 3
- 239000000155 melt Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 230000008520 organization Effects 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000008521 reorganization Effects 0.000 description 3
- 102220080600 rs797046116 Human genes 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000004448 titration Methods 0.000 description 3
- 108020005087 unfolded proteins Proteins 0.000 description 3
- OJHZNMVJJKMFGX-RNWHKREASA-N (4r,4ar,7ar,12bs)-9-methoxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;2,3-dihydroxybutanedioic acid Chemical compound OC(=O)C(O)C(O)C(O)=O.O=C([C@@H]1O2)CC[C@H]3[C@]4([H])N(C)CC[C@]13C1=C2C(OC)=CC=C1C4 OJHZNMVJJKMFGX-RNWHKREASA-N 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 241000282836 Camelus dromedarius Species 0.000 description 2
- 241000222173 Candida parapsilosis Species 0.000 description 2
- 241000222178 Candida tropicalis Species 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 241001508813 Clavispora lusitaniae Species 0.000 description 2
- 241000699800 Cricetinae Species 0.000 description 2
- 201000007336 Cryptococcosis Diseases 0.000 description 2
- 241000221204 Cryptococcus neoformans Species 0.000 description 2
- 241000580885 Cutaneotrichosporon curvatus Species 0.000 description 2
- 241000223233 Cutaneotrichosporon cutaneum Species 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 241000192484 Diutina catenulata Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 244000168141 Geotrichum candidum Species 0.000 description 2
- 235000017388 Geotrichum candidum Nutrition 0.000 description 2
- 241000178290 Geotrichum fermentans Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241001259715 Hannaella luteola Species 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 241001539803 Magnusiomyces capitatus Species 0.000 description 2
- 241000555688 Malassezia furfur Species 0.000 description 2
- 241001299738 Malassezia pachydermatis Species 0.000 description 2
- 241001123676 Metschnikowia pulcherrima Species 0.000 description 2
- 241000235048 Meyerozyma guilliermondii Species 0.000 description 2
- 108010004729 Phycoerythrin Proteins 0.000 description 2
- 241000235648 Pichia Species 0.000 description 2
- 241000235062 Pichia membranifaciens Species 0.000 description 2
- 241000223254 Rhodotorula mucilaginosa Species 0.000 description 2
- 241000123447 Solicoccozyma terreus Species 0.000 description 2
- 241001634922 Tausonia pullulans Species 0.000 description 2
- 241000222292 [Candida] magnoliae Species 0.000 description 2
- 241000222295 [Candida] zeylanoides Species 0.000 description 2
- 238000005267 amalgamation Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000006287 biotinylation Effects 0.000 description 2
- 238000007413 biotinylation Methods 0.000 description 2
- 229940055022 candida parapsilosis Drugs 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000006471 dimerization reaction Methods 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 230000000763 evoking effect Effects 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- -1 for example Proteins 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 238000013383 initial experiment Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 230000004660 morphological change Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000012846 protein folding Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000009790 rate-determining step (RDS) Methods 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 102200056889 rs6957768 Human genes 0.000 description 2
- 238000012807 shake-flask culturing Methods 0.000 description 2
- GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical class OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 description 1
- 241000159584 Aciculoconidium aculeatum Species 0.000 description 1
- 101710186708 Agglutinin Proteins 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 108010049777 Ankyrins Proteins 0.000 description 1
- 102000008102 Ankyrins Human genes 0.000 description 1
- 125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241000856666 Candida albicans var. stellatoidea Species 0.000 description 1
- 241001240437 Candida bentonensis Species 0.000 description 1
- 241001240438 Candida hispaniensis Species 0.000 description 1
- 241000222128 Candida maltosa Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 241001522864 Cryptococcus gattii VGI Species 0.000 description 1
- 241000123365 Cryptococcus neoformans var. neoformans Species 0.000 description 1
- 241001489178 Cyberlindnera petersonii Species 0.000 description 1
- 241001149409 Cystobasidium minutum Species 0.000 description 1
- 241000595495 Debaryomyces hansenii var. hansenii Species 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 241000222175 Diutina rugosa Species 0.000 description 1
- 238000012286 ELISA Assay Methods 0.000 description 1
- 241000178951 Endomyces Species 0.000 description 1
- 108700041152 Endoplasmic Reticulum Chaperone BiP Proteins 0.000 description 1
- 102100021451 Endoplasmic reticulum chaperone BiP Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 101001091269 Escherichia coli Hygromycin-B 4-O-kinase Proteins 0.000 description 1
- 241001506046 Farysia acheniorum Species 0.000 description 1
- 241000221420 Filobasidium uniguttulatum Species 0.000 description 1
- 241000726221 Gemma Species 0.000 description 1
- 102000000587 Glycerolphosphate Dehydrogenase Human genes 0.000 description 1
- 108010041921 Glycerolphosphate Dehydrogenase Proteins 0.000 description 1
- 101150112743 HSPA5 gene Proteins 0.000 description 1
- 241001149669 Hanseniaspora Species 0.000 description 1
- 101710146024 Horcolin Proteins 0.000 description 1
- 241000223198 Humicola Species 0.000 description 1
- 241000150860 Hyphopichia burtonii Species 0.000 description 1
- 101150108662 KAR2 gene Proteins 0.000 description 1
- 241000486799 Kazachstania pintolopesii Species 0.000 description 1
- 241001304302 Kuraishia capsulata Species 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 101710189395 Lectin Proteins 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001559185 Mammalian rubulavirus 5 Species 0.000 description 1
- 101710179758 Mannose-specific lectin Proteins 0.000 description 1
- 101710150763 Mannose-specific lectin 1 Proteins 0.000 description 1
- 101710150745 Mannose-specific lectin 2 Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 description 1
- 241000033319 Naganishia diffluens Species 0.000 description 1
- 241000320412 Ogataea angusta Species 0.000 description 1
- 241001489172 Ogataea glucozyma Species 0.000 description 1
- 241000235059 Ogataea pini Species 0.000 description 1
- 241000826199 Ogataea wickerhamii Species 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 241000222051 Papiliotrema laurentii Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000521553 Pichia fermentans Species 0.000 description 1
- 241000235645 Pichia kudriavzevii Species 0.000 description 1
- 235000005205 Pinus Nutrition 0.000 description 1
- 241000218602 Pinus <genus> Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 241000221418 Piskurozyma capsuligena Species 0.000 description 1
- 108010026552 Proteome Proteins 0.000 description 1
- 241000007095 Rhodotorula araucariae Species 0.000 description 1
- 241000223253 Rhodotorula glutinis Species 0.000 description 1
- 241001149408 Rhodotorula graminis Species 0.000 description 1
- 101100010928 Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) tuf gene Proteins 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 101100111629 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KAR2 gene Proteins 0.000 description 1
- 101100313649 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) POT1 gene Proteins 0.000 description 1
- 235000018370 Saccharomyces delbrueckii Nutrition 0.000 description 1
- 241000877401 Saccharomyces ellipsoideus Species 0.000 description 1
- 235000018368 Saccharomyces fragilis Nutrition 0.000 description 1
- 241000235348 Schizosaccharomyces japonicus Species 0.000 description 1
- 241001123649 Schwanniomyces polymorphus Species 0.000 description 1
- 241000228393 Sporidiobolus salmonicolor Species 0.000 description 1
- 241000222068 Sporobolomyces <Sporidiobolaceae> Species 0.000 description 1
- 241000123675 Sporobolomyces roseus Species 0.000 description 1
- 101001091268 Streptomyces hygroscopicus Hygromycin-B 7''-O-kinase Proteins 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 101150001810 TEAD1 gene Proteins 0.000 description 1
- 101150074253 TEF1 gene Proteins 0.000 description 1
- 241000006364 Torula Species 0.000 description 1
- 244000288561 Torulaspora delbrueckii Species 0.000 description 1
- 235000014681 Torulaspora delbrueckii Nutrition 0.000 description 1
- 102100029898 Transcriptional enhancer factor TEF-1 Human genes 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 239000006035 Tryptophane Substances 0.000 description 1
- 241001193070 Wickerhamomyces subpelliculosus Species 0.000 description 1
- 101100161758 Yarrowia lipolytica (strain CLIB 122 / E 150) POX3 gene Proteins 0.000 description 1
- 241000235017 Zygosaccharomyces Species 0.000 description 1
- 241000235033 Zygosaccharomyces rouxii Species 0.000 description 1
- 241000192392 [Candida] fennica Species 0.000 description 1
- 241000222126 [Candida] glabrata Species 0.000 description 1
- 241000191335 [Candida] intermedia Species 0.000 description 1
- 241000222296 [Candida] nitratophila Species 0.000 description 1
- 241000320458 [Cryptococcus] albidus var. kuetzingii Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 208000032343 candida glabrata infection Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000006652 catabolic pathway Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000002962 chemical mutagen Substances 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000011180 clone assessment Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 101150028578 grp78 gene Proteins 0.000 description 1
- 229940022353 herceptin Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- YQYJSBFKSSDGFO-FWAVGLHBSA-N hygromycin A Chemical compound O[C@H]1[C@H](O)[C@H](C(=O)C)O[C@@H]1Oc1ccc(\C=C(/C)C(=O)N[C@@H]2[C@@H]([C@H]3OCO[C@H]3[C@@H](O)[C@@H]2O)O)cc1O YQYJSBFKSSDGFO-FWAVGLHBSA-N 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 102000028557 immunoglobulin binding proteins Human genes 0.000 description 1
- 108091009323 immunoglobulin binding proteins Proteins 0.000 description 1
- 238000012744 immunostaining Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229940031154 kluyveromyces marxianus Drugs 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 230000005291 magnetic effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 238000011330 nucleic acid test Methods 0.000 description 1
- 210000002220 organoid Anatomy 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 238000002823 phage display Methods 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229920002704 polyhistidine Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 150000003839 salts Chemical group 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012882 sequential analysis Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
- C12N1/18—Baker's yeast; Brewer's yeast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Virology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Oncology (AREA)
- Botany (AREA)
- Tropical Medicine & Parasitology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29709310P | 2010-01-21 | 2010-01-21 | |
| US61/297,093 | 2010-01-21 | ||
| PCT/IB2011/000227 WO2011089527A1 (en) | 2010-01-21 | 2011-01-21 | Methods and compositions for displaying a poypeptide on a yeast cell surface |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102803491A true CN102803491A (zh) | 2012-11-28 |
Family
ID=44022829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011800148893A Pending CN102803491A (zh) | 2010-01-21 | 2011-01-21 | 用于在酵母细胞表面上展示多肽的方法和组合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20130096281A1 (enExample) |
| EP (1) | EP2526193A1 (enExample) |
| JP (1) | JP2013517761A (enExample) |
| KR (1) | KR20120118045A (enExample) |
| CN (1) | CN102803491A (enExample) |
| BR (1) | BR112012018163A2 (enExample) |
| CA (1) | CA2787677A1 (enExample) |
| SG (1) | SG182647A1 (enExample) |
| WO (1) | WO2011089527A1 (enExample) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105722387A (zh) * | 2013-09-18 | 2016-06-29 | 瑞泽恩制药公司 | 组氨酸工程改造的轻链抗体和用于生成所述抗体的经基因修饰的非人动物 |
| CN106701606A (zh) * | 2016-12-19 | 2017-05-24 | 广东启智生物科技有限公司 | 一种能降解利用餐厨废弃物的基因工程产朊假丝酵母及其构建方法 |
| CN108085332A (zh) * | 2017-12-27 | 2018-05-29 | 中国科学院青岛生物能源与过程研究所 | 一种细胞表面展示有豆壳过氧化物酶的重组酵母菌及其构建方法与应用 |
| CN111996132A (zh) * | 2020-07-21 | 2020-11-27 | 郑州大学 | 一种解脂耶氏酵母表面展示方法 |
| CN114606151A (zh) * | 2022-04-27 | 2022-06-10 | 南京工业大学 | 一种表面展示β-半乳糖苷酶的重组毕赤酵母及构建方法和应用 |
| CN115851460A (zh) * | 2022-08-10 | 2023-03-28 | 丁辰 | 一种具有激活哺乳动物干细胞分化功能的菌株、组合物及其应用 |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2508613A3 (en) | 2007-04-03 | 2012-11-28 | Oxyrane UK Limited | Glycosylation of molecules |
| JP5990102B2 (ja) | 2009-09-29 | 2016-09-07 | ユニフェルシテイト ヘント | ホスホ−６−マンノースへのマンノース−１−ホスホ−６−マンノース結合の加水分解 |
| BR112012011980A2 (pt) | 2009-11-19 | 2021-09-08 | Oxyrane Uk Limited | Métodos de produzir células transformadas de yarrowia lipolytica e proteínas-alvocompreendendo n-glicanos, células transformadas de yarrowia lipolytica e suas culturas, bem como composição compreendendo glicoproteínas |
| SG189110A1 (en) | 2010-09-29 | 2013-05-31 | Oxyrane Uk Ltd | De-mannosylation of phosphorylated n-glycans |
| CA2812870C (en) | 2010-09-29 | 2020-06-09 | Oxyrane Uk Limited | Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated n-glycans and methods of facilitating mammalian cellular uptake of glycoproteins |
| US20140243234A1 (en) * | 2011-08-03 | 2014-08-28 | Texas Biomedical Research Institute | Nucleic acid compositions, methods and kits for rapid pairing of affinity agents |
| CN104379162B (zh) | 2012-03-15 | 2017-03-15 | 奥克西雷恩英国有限公司 | 用于治疗蓬佩氏病的方法和材料 |
| HRP20201906T1 (hr) | 2013-12-20 | 2021-04-02 | Fred Hutchinson Cancer Research Center | Označene kimerne efektorske molekule i njihovi receptori |
| WO2016075314A1 (fr) | 2014-11-13 | 2016-05-19 | Institut National De La Recherche Agronomique | Identification de facteurs de transcription de yarrowia lipolytica affectant la production de proteines |
| FR3028527A1 (fr) | 2014-11-13 | 2016-05-20 | Pivert | Identification de facteurs de transcription de yarrowia lipolytica |
| US20160185633A1 (en) * | 2014-12-30 | 2016-06-30 | University Of Florida Research Foundation, Inc. | Recovery of nutrients from water and wastewater by precipitation as struvite |
| WO2016176652A2 (en) | 2015-04-29 | 2016-11-03 | Fred Hutchinson Cancer Research Center | Modified stem cells and uses thereof |
| EA201891521A1 (ru) * | 2016-01-08 | 2019-01-31 | ДСМ АйПи АССЕТС Б.В. | Переключение типа спаривания у yarrowia lipolytica |
| US10988759B2 (en) | 2016-01-15 | 2021-04-27 | University Of Washington | High throughput protein-protein interaction screening in yeast liquid culture |
| FR3081169B1 (fr) | 2018-05-15 | 2020-06-19 | Messenger Biopharma | Substitution de la coiffe des arn messagers par deux sequences d'arn introduites a leur extremite 5' |
| WO2021231013A1 (en) * | 2020-05-11 | 2021-11-18 | A-Alpha Bio, Inc. | High-throughput screening methods to identify small molecule targets |
| EP4158015A1 (en) | 2020-06-01 | 2023-04-05 | A-Alpha Bio, Inc. | Methods for characterizing and engineering protein-protein interactions |
| WO2023051972A1 (en) | 2021-09-29 | 2023-04-06 | Miltenyi Biotec B.V. & Co. KG | Method for the generation and selection of a producer cell |
| CN115786387B (zh) * | 2022-09-19 | 2024-02-13 | 苏州泓迅生物科技股份有限公司 | 一种通用型酵母细胞表面展示质粒载体及其应用 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999036569A1 (en) * | 1998-01-20 | 1999-07-22 | The Board Of Trustees Of The University Of Illinois | Yeast cell surface display of proteins and uses thereof |
| WO2003029456A1 (en) * | 2001-10-01 | 2003-04-10 | Dyax Corp. | Multi-chain eukaryotic display vectors and uses thereof |
| US20080171359A1 (en) * | 2005-04-14 | 2008-07-17 | Oxyrane (Uk) Ltd. | Recombinant Yeasts for Synthesizing Epoxide Hydrolases |
| WO2008100816A2 (en) * | 2007-02-09 | 2008-08-21 | Medimmune, Llc | Antibody libray display by yeast cell plasma membrane |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US6042828A (en) | 1992-09-07 | 2000-03-28 | Kyowa Hakko Kogyo Co., Ltd. | Humanized antibodies to ganglioside GM2 |
| US6699658B1 (en) * | 1996-05-31 | 2004-03-02 | Board Of Trustees Of The University Of Illinois | Yeast cell surface display of proteins and uses thereof |
| US7442772B2 (en) | 1997-12-03 | 2008-10-28 | Genentech, Inc. | Antibodies to PRO361 polypeptide |
| WO2001042462A2 (en) | 1999-12-08 | 2001-06-14 | National University Of Singapore | Phospholipase a2 inhibitory peptides from python reticulatus |
| MXPA04009418A (es) | 2002-03-29 | 2005-06-08 | Schering Corp | Anticuerpos monoclonales humanos par interleucina-5, y metodos y composiciones que comprenden los mismos. |
| CA2501422C (en) | 2004-04-29 | 2014-08-12 | University Of Rochester | Lymphoid chemokines in the diagnosis, monitoring and treatment of autoimmune disease |
| US7431927B2 (en) | 2005-03-24 | 2008-10-07 | Epitomics, Inc. | TNFα-neutralizing antibodies |
-
2011
- 2011-01-21 WO PCT/IB2011/000227 patent/WO2011089527A1/en not_active Ceased
- 2011-01-21 KR KR1020127021903A patent/KR20120118045A/ko not_active Withdrawn
- 2011-01-21 BR BR112012018163A patent/BR112012018163A2/pt not_active IP Right Cessation
- 2011-01-21 CN CN2011800148893A patent/CN102803491A/zh active Pending
- 2011-01-21 EP EP11710288A patent/EP2526193A1/en not_active Withdrawn
- 2011-01-21 US US13/574,126 patent/US20130096281A1/en not_active Abandoned
- 2011-01-21 SG SG2012053948A patent/SG182647A1/en unknown
- 2011-01-21 CA CA2787677A patent/CA2787677A1/en not_active Abandoned
- 2011-01-21 JP JP2012549441A patent/JP2013517761A/ja active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999036569A1 (en) * | 1998-01-20 | 1999-07-22 | The Board Of Trustees Of The University Of Illinois | Yeast cell surface display of proteins and uses thereof |
| WO2003029456A1 (en) * | 2001-10-01 | 2003-04-10 | Dyax Corp. | Multi-chain eukaryotic display vectors and uses thereof |
| US20080171359A1 (en) * | 2005-04-14 | 2008-07-17 | Oxyrane (Uk) Ltd. | Recombinant Yeasts for Synthesizing Epoxide Hydrolases |
| WO2008100816A2 (en) * | 2007-02-09 | 2008-08-21 | Medimmune, Llc | Antibody libray display by yeast cell plasma membrane |
Non-Patent Citations (2)
| Title |
|---|
| BODER ET AL.: "Yeast surface dispaly for screening combination polypeptide libraries", 《NATURE BIOTECHNOLOGY》, vol. 15, 30 June 1997 (1997-06-30), pages 553 - 557 * |
| LIXI YUE ET AL.: "Construction of a new plasmid for surface display oncells of Yarrowia lipolytica", 《JOURNAL OF MICROBIOLOGICAL METHODS》, vol. 72, no. 2, 29 February 2008 (2008-02-29), pages 116 - 123, XP022420000 * |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105722387A (zh) * | 2013-09-18 | 2016-06-29 | 瑞泽恩制药公司 | 组氨酸工程改造的轻链抗体和用于生成所述抗体的经基因修饰的非人动物 |
| CN105722387B (zh) * | 2013-09-18 | 2020-01-17 | 瑞泽恩制药公司 | 组氨酸工程改造的轻链抗体和用于生成所述抗体的经基因修饰的非人动物 |
| CN106701606A (zh) * | 2016-12-19 | 2017-05-24 | 广东启智生物科技有限公司 | 一种能降解利用餐厨废弃物的基因工程产朊假丝酵母及其构建方法 |
| CN108085332A (zh) * | 2017-12-27 | 2018-05-29 | 中国科学院青岛生物能源与过程研究所 | 一种细胞表面展示有豆壳过氧化物酶的重组酵母菌及其构建方法与应用 |
| CN108085332B (zh) * | 2017-12-27 | 2020-11-27 | 中国科学院青岛生物能源与过程研究所 | 一种细胞表面展示有豆壳过氧化物酶的重组酵母菌及其构建方法与应用 |
| CN111996132A (zh) * | 2020-07-21 | 2020-11-27 | 郑州大学 | 一种解脂耶氏酵母表面展示方法 |
| CN114606151A (zh) * | 2022-04-27 | 2022-06-10 | 南京工业大学 | 一种表面展示β-半乳糖苷酶的重组毕赤酵母及构建方法和应用 |
| CN114606151B (zh) * | 2022-04-27 | 2023-05-19 | 南京工业大学 | 一种表面展示β-半乳糖苷酶的重组毕赤酵母及构建方法和应用 |
| CN115851460A (zh) * | 2022-08-10 | 2023-03-28 | 丁辰 | 一种具有激活哺乳动物干细胞分化功能的菌株、组合物及其应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011089527A1 (en) | 2011-07-28 |
| CA2787677A1 (en) | 2011-07-28 |
| JP2013517761A (ja) | 2013-05-20 |
| SG182647A1 (en) | 2012-08-30 |
| EP2526193A1 (en) | 2012-11-28 |
| BR112012018163A2 (pt) | 2019-09-24 |
| KR20120118045A (ko) | 2012-10-25 |
| US20130096281A1 (en) | 2013-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102803491A (zh) | 用于在酵母细胞表面上展示多肽的方法和组合物 | |
| Rakestraw et al. | Directed evolution of a secretory leader for the improved expression of heterologous proteins and full‐length antibodies in Saccharomyces cerevisiae | |
| CN1871359B (zh) | 使用单倍体交配策略在酵母中合成异聚多亚基多肽的方法 | |
| US5024941A (en) | Expression and secretion vector for yeast containing a glucoamylase signal sequence | |
| Oda et al. | Identification of a cytoplasm to vacuole targeting determinant in aminopeptidase I. | |
| WO2004020404A2 (en) | Modified transferin-antibody fusion proteins | |
| CN110055248A (zh) | 可调控启动子 | |
| CN102268094A (zh) | 被修饰的转铁蛋白抗体的融合蛋白 | |
| WO2005070962A1 (en) | Production of a monoclonal antibody in a heterokaryon fungus or in a fungal host cell | |
| JP2021505675A (ja) | ペリプラズム空間中におけるタンパク質の酵母ディスプレイ | |
| Lin et al. | Dual N-and C-terminal helices are required for endoplasmic reticulum and lipid droplet association of alcohol acetyltransferases in Saccharomyces cerevisiae | |
| Fukunishi et al. | The fission yeast spore is coated by a proteinaceous surface layer comprising mainly Isp3 | |
| CN104531734A (zh) | 改善的细菌膜蛋白分泌 | |
| TW201313899A (zh) | 在經轉形的微生物如巴斯德畢赤氏酵母中的多－複製策略用於多－次級單元的蛋白質如抗體之高效價且高純度生產技術 | |
| Liu et al. | Targeted introduction of a diphtheria toxin resistant mutation into the chromosomal EF-2 locus of Pichia pastoris and expression of immunotoxin in the EF-2 mutants | |
| CN102741403A (zh) | 二硫键连接的二聚体蛋白质在丝状噬菌体上的展示 | |
| Bleve et al. | Subcellular localization and functional expression of the glycerol uptake protein 1 (GUP1) of Saccharomyces cerevisiae tagged with green fluorescent protein | |
| EP2990485A1 (en) | Fd chain gene or l chain gene each capable of increasing secretion amount of fab-type antibody | |
| Shiota et al. | The Tom40 assembly process probed using the attachment of different intramitochondrial sorting signals | |
| US20120202244A1 (en) | Antibodies Capable of Specifically Binding to a Specific Amino Acid Sequence | |
| Shin | Yeast as a Heterologous Expression System and structural characterisation of clinically relevant proteins | |
| Kjærulff et al. | Alternative protein secretion: the Mam1 ABC transporter supports secretion of M-factor linked GFP in fission yeast | |
| Koubaa et al. | Yarrowia Lipolytica Yeast: From Metabolic Engineering to Biotechnological Applications | |
| Hsieh | Engineering the yeast Kluyveromyces lactis for the high level expression of heterologous genes | |
| EP4642916A2 (en) | Secretion signals |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20121128 |